With each year, the number of studies with evidence showing medical marijuana’s therapeutic effectiveness grows even larger.
NORML this week updated and revised its publication, Clinical Applications For Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021.
This updated edition reviews more than 450 peer-reviewed studies.
The studies examine the safety and efficacy of either whole-plant Cannabis or individual cannabinoids in 23 different patient populations. Patients helped include those with autism, chronic pain, diabetes, fibromyalgia, migraine, and post-traumatic stress.
Since NORML issued the previous edition of this report in 2017, scientists have published thousands more studies relevant to the medicinal properties of marijuana.
This is reflected in NORML’s new report, which highlights nearly 100 newly published studies. This makes it one of the most up-to-date and comprehensive compendiums on the utility of medical Cannabis available.
Despite claims by some that marijuana has yet to be subject to adequate scientific scrutiny, scientific interest in the herb has increased exponentially in recent years.
In 2020, researchers worldwide published a record 3,500+ scientific papers on the subject of Cannabis, according to data compiled by the National Library of Medicine and PubMed.gov. So far this year, scientists have published more than 2,600 papers.
In all, PubMed.gov now cites more than 37,000 scientific papers on the topic of marijuana.
To read the full text of NORML’s 2021 publication, visit: